IM Cannabis (IMCC) Other Working Capital Changes (2024 - 2025)
IM Cannabis' (IMCC) quarterly Other Working Capital Changes came in at -$79929.9 in Q3 2025, down 60.35% year-on-year from -$201580.1 in Q3 2024, and down 112.98% quarter-over-quarter from -$37529.0 in Q2 2025.
IM Cannabis (IMCC) Other Working Capital Changes (2024 - 2025) Analysis & Trends
IM Cannabis' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$79929.9 for Q3 2025.
- On a quarterly basis, Other Working Capital Changes fell 60.35% year-over-year to -$79929.9 in Q3 2025; TTM through Sep 2025 was -$212095.3, a 30.71% increase from a year earlier, with the FY2024 full-year figure at -$241762.2, up 44.34% from the prior year.
- Other Working Capital Changes fell to -$79929.9 in Q3 2025 per IMCC's latest filing, from -$37529.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.3 million in Q4 2024 and bottomed at -$1.8 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$87569.4 (2024), against an average of -$136689.2.
- Across the five-year window, Other Working Capital Changes tumbled 876.04% in 2021 and surged 265.5% in 2022, its largest moves.
- Year by year, Other Working Capital Changes stood at -$226100.8 in 2021, then slumped by 89.31% to -$428024.4 in 2022, then surged by 74.09% to -$110914.9 in 2023, then soared by 57.4% to -$47246.0 in 2024, then sank by 69.18% to -$79929.9 in 2025.
- Per Business Quant, the three latest IMCC Other Working Capital Changes figures stand at -$79929.9 (Q3 2025), -$37529.0 (Q2 2025), and -$47390.3 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.25 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Sep 30, 2025 | -143,147.10 |
| Sep 30, 2025 | -143,147.10 |
| Sep 30, 2025 | -143,147.10 |
| Dec 31, 2024 | 3.35 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.85 Mn |